Immunovia
Diagnostics company developing a blood test for early pancreatic cancer detection.
IMMNOV | ST
Overview
Corporate Details
- ISIN(s):
- SE0006091997 (+2 more)
- LEI:
- 549300KHWL6KK1XGUO81
- Country:
- Sweden
- Address:
- Scheelevägen 8, 223 63 LUND
- Website:
- https://immunovia.com/
- Industry:
- Other human health activities
Description
Immunovia is a diagnostics company focused on revolutionizing the early detection of pancreatic cancer. Its primary product is the PancreaSure test, a simple blood test designed to detect pancreatic cancer at Stage 1 and 2 with high accuracy. The test is intended for annual surveillance of individuals at elevated risk due to family history or genetic mutations. PancreaSure functions by detecting proteins and other biomarkers indicative of pancreatic cancer growth. The company's mission is to improve survival rates for this highly lethal cancer by enabling diagnosis at its earliest, most treatable stages, offering a convenient alternative to invasive imaging procedures.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2020-08-31 08:30 |
KALLELSE TILL EXTRA BOLAGSSTÄMMA I IMMUNOVIA AB
|
Swedish | PDF • 240.9 KB | ||
| 2020-08-31 08:30 |
NOTICE OF EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB
|
English | PDF • 238.1 KB | ||
| 2020-08-26 08:30 |
Immunovia annonserar VD succession: Utser Patrik Dahlen till ny VD
|
Swedish | PDF • 197.9 KB | ||
| 2020-08-26 08:30 |
Immunovia Announces CEO Transition: Appoints Patrik Dahlen as New CEO
|
English | PDF • 195.6 KB | ||
| 2020-08-20 16:00 | Swedish | PDF • 1.0 MB | |||
| 2020-08-20 16:00 |
Immunovia Reports Second Quarter Interim Report January – June 2020
|
English | PDF • 1.0 MB | ||
| 2020-08-20 16:00 |
Immunovia rapporterar delårsrapport för andra kvartalet januari - juni 202
|
Swedish | PDF • 1.0 MB | ||
| 2020-06-30 09:00 |
Change in the number of shares and votes in Immunovia AB (publ)
|
English | PDF • 171.2 KB | ||
| 2020-06-30 09:00 |
Förändring av antal aktier och röster i Immunovia AB (publ)
|
Swedish | PDF • 190.4 KB | ||
| 2020-06-30 08:45 |
Immunovia Targeting Long-Term Market Penetration of 30% for IMMray™ PanCan-d
|
English | PDF • 191.6 KB | ||
| 2020-06-30 08:45 |
Immunovia sätter mål för långsiktig marknadspenetration på 30 procent för IMMra…
|
Swedish | PDF • 187.7 KB | ||
| 2020-06-26 09:00 |
Immunovia utökar sitt lungcancerprogram baserat på l ovande resultat från den a…
|
Swedish | PDF • 261.6 KB | ||
| 2020-06-26 09:00 |
Immunovia Expands its Lung Cancer Program Based on Encouraging Results from the…
|
English | PDF • 265.3 KB | ||
| 2020-06-09 18:05 |
Immunovia raised ~ 400m SEK to Further Accelerate the Market Introduction of th…
|
English | PDF • 184.7 KB | ||
| 2020-06-09 18:03 |
Immunovia tillfördes cirka 400 MSEK för att ytterligare påskynda marknadsintrod…
|
Swedish | PDF • 179.6 KB |
Automate Your Workflow. Get a real-time feed of all Immunovia filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Immunovia
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Immunovia via our API.
Peer Companies
